DalsnaFinance › IPOs › Stoke Therapeutics Inc › IPO
Stoke Therapeutics, Inc. completed its initial public offering on NASDAQ on June 19, 2019, pricing at $18.00 a share.
| Ticker | STOK |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 19, 2019 |
| Offering price | $18.00 |
| Shares offered | 7,891,110 |
| Total raised | $142M |
Stoke Therapeutics, Inc. sold 7,891,110 shares at $18.00 each on NASDAQ. Multiplied out, that is $142 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $142 million total recorded for the deal.
Stoke Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Stoke Therapeutics, Inc.. This page is general information, not investment advice.